Surgalign Holdings Valuation
| SRGADelisted Stock | USD 0.04 0 12.54% |
Surgalign Holdings seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Surgalign Holdings from inspecting the company fundamentals such as Operating Margin of (0.68) %, shares outstanding of 9.18 M, and Return On Equity of -14.97 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Surgalign Holdings' price fluctuation is very steady at this time. Calculation of the real value of Surgalign Holdings is based on 3 months time horizon. Increasing Surgalign Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Surgalign Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Surgalign Stock. However, Surgalign Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.035 | Real 0.0333 | Hype 0.04 | Naive 0.3 |
The real value of Surgalign Stock, also known as its intrinsic value, is the underlying worth of Surgalign Holdings Company, which is reflected in its stock price. It is based on Surgalign Holdings' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Surgalign Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Surgalign Holdings helps investors to forecast how Surgalign stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Surgalign Holdings more accurately as focusing exclusively on Surgalign Holdings' fundamentals will not take into account other important factors: Surgalign Holdings Total Value Analysis
Surgalign Holdings is at this time forecasted to have valuation of (7.93 M) with market capitalization of 1.68 M, debt of 10.19 M, and cash on hands of 29.34 M. The negative valuation of Surgalign Holdings may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Surgalign Holdings fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(7.93 M) | 1.68 M | 10.19 M | 29.34 M |
Surgalign Holdings Investor Information
About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.79. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Surgalign Holdings recorded a loss per share of 8.12. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 17th of May 2022. Based on the key indicators related to Surgalign Holdings' liquidity, profitability, solvency, and operating efficiency, Surgalign Holdings is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Surgalign Holdings Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Surgalign Holdings has an asset utilization ratio of 116.71 percent. This suggests that the Company is making $1.17 for each dollar of assets. An increasing asset utilization means that Surgalign Holdings is more efficient with each dollar of assets it utilizes for everyday operations.Surgalign Holdings Ownership Allocation
Surgalign Holdings has significant amount of outstanding shares owned by insiders and institutional investors .Surgalign Holdings Profitability Analysis
The company reported the previous year's revenue of 81.98 M. Net Loss for the year was (54.6 M) with profit before overhead, payroll, taxes, and interest of 40.29 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Surgalign Holdings' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Surgalign Holdings and how it compares across the competition.
About Surgalign Holdings Valuation
The delisted stock valuation mechanism determines Surgalign Holdings' current worth on a weekly basis. Our valuation model uses a comparative analysis of Surgalign Holdings. We calculate exposure to Surgalign Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Surgalign Holdings's related companies.Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois. Surgalign Hldg operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 231 people.
Surgalign Holdings Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 6.6 M | |
| Forward Price Earnings | 526.3158 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Surgalign Stock
If you are still planning to invest in Surgalign Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Surgalign Holdings' history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |